Related references
Note: Only part of the references are listed.Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells
Jens Loebbermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats
Tobias Kamphuis et al.
VACCINE (2013)
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
Gregory M. Glenn et al.
VACCINE (2013)
Mechanisms of Respiratory Syncytial Virus Modulation of Airway Immune Responses
Matthew T. Lotz et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2012)
Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication
Nico Marr et al.
INNATE IMMUNITY (2012)
Long-Term and Memory Immune Responses in Mice against Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus Glycoprotein Ectodomains
Madelyn R. Schmidt et al.
JOURNAL OF VIROLOGY (2012)
Increased Genetic and Phenotypic Stability of a Promising Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate by Reverse Genetics
Cindy Luongo et al.
JOURNAL OF VIROLOGY (2012)
The Respiratory Syncytial Virus G Protein Conserved Domain Induces a Persistent and Protective Antibody Response in Rodents
Thien N. Nguyen et al.
PLOS ONE (2012)
Nucleoprotein Nanostructures Combined with Adjuvants Adapted to the Neonatal Immune Context: A Candidate Mucosal RSV Vaccine
Aude Remot et al.
PLOS ONE (2012)
Immunogenicity and Protective Capacity of a Virosomal Respiratory Syncytial Virus Vaccine Adjuvanted with Monophosphoryl Lipid A in Mice
Tobias Kamphuis et al.
PLOS ONE (2012)
Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children
David I. Bernstein et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice
Yoshihiko Murata et al.
VACCINE (2012)
Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands
Muhammad Shafique et al.
VACCINE (2012)
Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles
S. Garlapati et al.
VACCINE (2012)
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
Bart G. Jones et al.
VACCINE (2012)
Nonclinical phenotypic and genotypic analyses of a Phase 1 pediatric respiratory syncytial virus vaccine candidate MEDI-559 (rA2cp248/404/1030ΔSH) at permissive and non-permissive temperatures
Jeanne H. Schickli et al.
VIRUS RESEARCH (2012)
Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines
Ruihong Zeng et al.
VIRUS RESEARCH (2012)
An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice
Anu Cherukuri et al.
IMMUNITY & AGEING (2012)
Baculovirus-based Vaccine Displaying Respiratory Syncytial Virus Glycoprotein Induces Protective Immunity against RSV Infection without Vaccine-Enhanced Disease
Sol Kim et al.
Immune Network (2012)
IL-17-Induced Pulmonary Pathogenesis during Respiratory Viral Infection and Exacerbation of Allergic Disease
Sumanta Mukherjee et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Respiratory syncytial virus disease: update on treatment and prevention
Leonard R. Krilov
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Respiratory syncytial virus vaccine development
Julia L. Hurwitz
EXPERT REVIEW OF VACCINES (2011)
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2011)
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Fu-Shi Quan et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins
Lori W. McGinnes et al.
JOURNAL OF VIROLOGY (2011)
Age-Dependent Maturation of Toll-Like Receptor-Mediated Cytokine Responses in Gambian Infants
Sarah Burl et al.
PLoS One (2011)
A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease
Dennis M. Lindell et al.
PLOS ONE (2011)
Pattern Recognition Receptors and Genetic Risk for RSV Infection: Value for Clinical Decision-Making?
Mika Ramet et al.
PEDIATRIC PULMONOLOGY (2011)
Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo
Thomas J. Powell et al.
VACCINE (2011)
Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine
Anja Krause et al.
VIROLOGY JOURNAL (2011)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Clearance of HIV Type 1 Envelope Recombinant Sendai Virus Depends on CD4+ T Cells and Interferon-γ But Not B Cells, CD8+ T Cells, or Perforin
Sherri L. Surman et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus
John P. DeVincenzo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice
Yuan-hui Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus
J. L. L. KIMPEN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Identification of and Human Serum Reactogenicity to Neutralizing Epitopes within the Central Unglycosylated Region of the Respiratory Syncytial Virus Attachment Protein
Yoshihiko Murata et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
New insights for development of a safe and protective RSV vaccine
Jorge C. G. Blanco et al.
HUMAN VACCINES (2010)
Therapeutic targeting of respiratory syncytial virus G-protein
Lawrence M. Kauvar et al.
IMMUNOTHERAPY (2010)
Foxp3+ CD4 Regulatory T Cells Limit Pulmonary Immunopathology by Modulating the CD8 T Cell Response during Respiratory Syncytial Virus Infection
Ross B. Fulton et al.
JOURNAL OF IMMUNOLOGY (2010)
Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Guerin Promotes Virus Clearance and Protects from Infection
Kelly M. Cautivo et al.
JOURNAL OF IMMUNOLOGY (2010)
Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice
Wenliang Zhang et al.
JOURNAL OF VIROLOGY (2010)
Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent
K. A. Shirey et al.
MUCOSAL IMMUNOLOGY (2010)
Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein
Yoshihiko Murata et al.
VACCINE (2010)
Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection
Sol Kim et al.
VACCINE (2010)
A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats
Myra N. Widjojoatmodjo et al.
VIROLOGY JOURNAL (2010)
Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice
Yuanhui Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Phenotype and function of neonatal DC
Fabienne Willems et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The host response and molecular pathogenesis associated with respiratory syncytial virus infection
Christine M. Oshansky et al.
FUTURE MICROBIOLOGY (2009)
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients
Ellen J. Collarini et al.
JOURNAL OF IMMUNOLOGY (2009)
Protective Efficacy and Immunogenicity of an Adenoviral Vector Vaccine Encoding the Codon-Optimized F Protein of Respiratory Syncytial Virus
Rebekka Kohlmann et al.
JOURNAL OF VIROLOGY (2009)
The Burden of Respiratory Syncytial Virus Infection in Young Children
Caroline Breese Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Policy Statement-Modified Recommendations for Use of Palivizumab for Prevention of Respiratory Syncytial Virus Infections
Joseph A. Bocchini et al.
PEDIATRICS (2009)
A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age
Joanne M. Langley et al.
VACCINE (2009)
The Role of Toll-like Receptors in Regulating the Immune Response against Respiratory Syncytial Virus
Peter Klein Klouwenberg et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction
Masashi Shingai et al.
INTERNATIONAL IMMUNOLOGY (2008)
The Secreted Form of Respiratory Syncytial Virus G Glycoprotein Helps the Virus Evade Antibody-Mediated Restriction of Replication by Acting as an Antigen Decoy and through Effects on Fc Receptor-Bearing Leukocytes
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2008)
Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG
Susan M. Bueno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults
Roderick S. Tang et al.
VACCINE (2008)
Regulation of immunity to respiratory syncytial virus by dendritic cells, toll-like receptors, and notch
Nicholas W. Lukacs et al.
VIRAL IMMUNOLOGY (2008)
Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection
Jae-Rang Yu et al.
JOURNAL OF VIROLOGY (2008)
Viral and host factors in human respiratory syncytial virus pathogenesis
Peter L. Collins et al.
JOURNAL OF VIROLOGY (2008)
Innate immunity in respiratory syncytial virus bronchiolitis
Rosalind L. Smyth
EXPERIMENTAL LUNG RESEARCH (2007)
Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats
Hoyin Mok et al.
JOURNAL OF VIROLOGY (2007)
Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques
Matthew B. Elliott et al.
VACCINE (2007)
A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis
Howard M. Corneli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Common human Toll-like receptor 4 polymorphisms - Role in susceptibility to respiratory syncytial virus infection and functional immunological relevance
Stephane C. Paulus et al.
CLINICAL IMMUNOLOGY (2007)
Innate immunity of the newborn: basic mechanisms and clinical correlates
Ofer Levy
NATURE REVIEWS IMMUNOLOGY (2007)
Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment
Tatiana Bousse et al.
VIRUS RESEARCH (2006)
The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease
Marina S. Boukhvalova et al.
VACCINE (2006)
Developing and maintaining protective CD8(+) memory T cells
Matthew A. Williams et al.
IMMUNOLOGICAL REVIEWS (2006)
Respiratory syncytial virus load predicts disease severity in previously healthy infants
JP DeVincenzo et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
RA Karron et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A Toll-like receptor in horseshoe crabs
K Inamori et al.
IMMUNOLOGICAL REVIEWS (2004)
Evaluation of BBG2Na in infant macaques:: specific immune responses after vaccination and RSV challenge
L de Waal et al.
VACCINE (2004)
Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis
A Gagro et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Respiratory syncytial virus-induced immunoprotection and immunopathology
JE Durbin et al.
VIRAL IMMUNOLOGY (2004)
Safety and immunogenicity of intranasal murine parainfluenza virus type I (Sendai virus) in healthy human adults
KS Slobod et al.
VACCINE (2004)
Pathogenesis of respiratory syncytial virus infection
RA Tripp
VIRAL IMMUNOLOGY (2004)
Respiratory syncytial virus and other pneumoviruses: a review of the international symposium-RSV 2003
AC Schmidt et al.
VIRUS RESEARCH (2004)
Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease
G Tal et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Innate immune responses in respiratory syncytial virus infections
S Krishnan et al.
VIRAL IMMUNOLOGY (2004)
Gene-gun DNA vaccination aggravates respiratory syncytial virus-induced pneumonitis
C Bartholdy et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Recombinant respiratory syncytial virus lacking secreted glycoprotein G is attenuated, non-pathogenic but induces protective immunity
CF Maher et al.
MICROBES AND INFECTION (2004)
Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin
MM Monick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines
AP Durbin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response
J Harris et al.
CELLULAR MICROBIOLOGY (2003)
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women
FM Munoz et al.
VACCINE (2003)
Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis
PA Piedra et al.
VACCINE (2003)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Respiratory syncytial virus-induced activation of nuclear factor-κB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways
HA Haeberle et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L
JD Ahlers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A role for immune complexes in enhanced respiratory syncytial virus disease
FP Polack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung
GM Spiekermann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Comparison of corticosteroids for treatment of respiratory syncytial virus bronchiolitis and pneumonia in cotton rats
MG Ottolini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock
E Lorenz et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults
UF Power et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Influence of maternal antibodies on neonatal immunization against respiratory viruses
JE Crowe
CLINICAL INFECTIOUS DISEASES (2001)
Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus
LM Haynes et al.
JOURNAL OF VIROLOGY (2001)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus
MN Fleeton et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Respiratory syncytial virus infection of gene gun vaccinated mice induces Th2-driven pulmonary eosinophilia even in the absence of sensitisation to the fusion (F) or attachment (G) protein
GP Bembridge et al.
VACCINE (2000)
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid
GA Prince et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats
GA Prince et al.
JOURNAL OF VIROLOGY (2000)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
NC Arbour et al.
NATURE GENETICS (2000)
Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides
F Cano et al.
VACCINE (2000)
CD4+ T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment
H Plotnicky-Gilquin et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
